NCT02984111View on ClinicalTrials.gov

Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

June 30, 2017

Conditions
Myocardial Ischemic Reperfusion Injury
Interventions
DRUG

normal saline

DRUG

erythropoietin

Trial Locations (1)

199873438

Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences., Tehran

All Listed Sponsors
collaborator

Pooyesh Darou

OTHER

lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT02984111 - Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery | Biotech Hunter | Biotech Hunter